Showing results (61-70 of 166) with videos related to

Sort By:
Pageof 17
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Comparing visual inspection with acetic acid, with and without Lugol's Iodine for triage of HPV self-sample positive women in Ethiopia: a randomized controlled trialSelamawit Fisseha Mekuria, Habtamu Biazin, Tamrat Abebe, et al.
American Journal of Hematology|September 9, 2015
Long-term survival in young and middle-aged Hodgkin lymphoma patients in Sweden 1992-2009-trends in cure proportions by clinical characteristicsIngrid Glimelius, Sara Ekberg, Mats Jerkeman, et al.
BMC Cancer|April 27, 2018
Bortezomib prevents cytarabine resistance in MCL, which is characterized by down-regulation of dCK and up-regulation of SPIB resulting in high NF-κB activityCatja Freiburghaus, Venera Kuci Emruli, Angelica Johansson, et al.
American Journal of Hematology|October 22, 2009
Identification of molecular targets associated with transformed diffuse large B cell lymphoma using highly purified tumor cellsUlrika Andréasson, Michael Dictor, Mats Jerkeman, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 3, 2024
Comparing visual inspection with acetic acid, with and without Lugol's Iodine for triage of HPV self-sample positive women in Ethiopia: a randomized controlled trialSelamawit Fisseha Mekuria, Habtamu Biazin, Tamrat Abebe, et al.
Cancer Medicine|December 15, 2017
Simplicity at the cost of predictive accuracy in diffuse large B-cell lymphoma: a critical assessment of the R-IPI, IPI, and NCCN-IPIJorne Biccler, Sandra Eloranta, Peter de Nully Brown, et al.
Hematological Oncology|October 29, 2021
Pre-treatment health-related quality of life parameters have prognostic impact in patients >65 years with newly diagnosed mantle cell lymphoma: The Nordic Lymphoma Group MCL4 (LENA-BERIT) experienceÅsa Lindberg, Christian Winther Eskelund, Alexandra Albertsson-Lindblad, et al.
Leukemia & Lymphoma|September 6, 2007
CD40 expression identifies a prognostically favourable subgroup of diffuse large B-cell lymphomaJohan Linderoth, Mats Ehinger, Mats Jerkeman, et al.
Blood|December 4, 2004
High expression of cyclin B1 predicts a favorable outcome in patients with follicular lymphomaErik Björck, Sara Ek, Ola Landgren, et al.
European Journal of Haematology|August 14, 2012
High serum vascular endothelial growth factor level is an adverse prognostic factor for high-risk diffuse large B-cell lymphoma patients treated with dose-dense chemoimmunotherapySari Riihijärvi, Heidi Nurmi, Harald Holte, et al.
Pageof 17